Sipelyte, Rusne
Metaxa, Athina Marina
Article History
Accepted: 19 March 2025
First Online: 1 April 2025
Declarations
:
: Both authors are currently employees of IDEA Pharma, a pharmaceutical strategy consultancy in London, United Kingdom. The work that formed the basis of this study was conducted as part of author RS’s UCL School of Pharmacy MSc dissertation from May to August 2024. No funding was received for conducting this study. The authors have no further competing interests to declare that are relevant to the content of this article.